The relationship between cyclo-oxygenase isoforms and platelets in the cardiothoracic system
At present, the cyclo-oxygenase inhibitor aspirin and the P2Y12 receptor blocker clopidogrel are commonly combined to prevent recurrent thrombosis after acute coronary syndrome events. Variable responses to this drug combination have driven the development of prasugrel and ticagrelor, two more poten...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2012
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.550870 |